
ISSN 0195-668X
EISSN 1522-9645
Issue navigation
Volume 46, Issue 14, 7 April 2025
Issue @ A Glance
Focus on blood pressure: sex-specific association with atrial fibrillation, role of gliflozins in hypertension, and new therapeutic targets in hypertension and orthostatic hypotension
Filippo Crea
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1277–1280, https://doi.org/10.1093/eurheartj/ehaf163
CardioPulse
European Heart Agency: 12-year European Society of Cardiology presence in Brussels
Panos E Vardas
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1281–1283, https://doi.org/10.1093/eurheartj/ehae879
Oriental Congress of Cardiology in China: past, present, and future perspectives
Yiqing Hu and others
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1284–1287, https://doi.org/10.1093/eurheartj/ehae848
ERC-funded Advanced Grant: creating molecular polypills
Georgios Krilis and others
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1288–1290, https://doi.org/10.1093/eurheartj/ehae866
Focus Issue on Hypertension, Diabetes and Metabolic Disorders
Clinical Research
Long-term pulse pressure trajectories and risk of incident atrial fibrillation: the Tromsø Study
Ekaterina Sharashova and others
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1291–1300, https://doi.org/10.1093/eurheartj/ehaf005
Editorial
Sex-specific pathways from vascular ageing to cardiac damage: unfavourable pulse pressure trajectories induce atrial fibrillation in women
Rosa Maria Bruno and Emmanuelle Vidal Petiot
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1301–1303, https://doi.org/10.1093/eurheartj/ehaf039
Clinical Research
Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
Michael Böhm and others
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1304–1317, https://doi.org/10.1093/eurheartj/ehae938
Editorial
SGLT2 inhibitors: not for hypertension but exceedingly useful in hypertension
Franz H Messerli and others
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1318–1320, https://doi.org/10.1093/eurheartj/ehae751
Clinical Research
Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease
John W Ostrominski and others
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1321–1331, https://doi.org/10.1093/eurheartj/ehae780
Editorial
The recent renewed interest among cardiologists in detecting and preventing diabetes is welcomed
Anna Norhammar and Viveca Ritsinger
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1332–1334, https://doi.org/10.1093/eurheartj/ehae833
Translational Science
Dendritic cell mineralocorticoid receptor controls blood pressure by regulating T helper 17 differentiation: role of the Plcβ1/4–Stat5–NF-κB pathway
Yong-Li Wang and others
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1335–1351, https://doi.org/10.1093/eurheartj/ehae670
Editorial
Immunometabolic switch in hypertension: how dendritic cell mineralocorticoid receptors drive Th17 polarization and blood pressure control
Tomasz P Mikolajczyk and others
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1352–1354, https://doi.org/10.1093/eurheartj/ehae863
Rapid Communications
Carbon dioxide for neurogenic orthostatic hypotension in adults: a novel therapy
Jacquie R Baker and others
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1355–1357, https://doi.org/10.1093/eurheartj/ehae653
Cardiovascular Flashlights
Myxoedema coma and myxoedema heart disease
Philip Haaf and others
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Page 1358, https://doi.org/10.1093/eurheartj/ehae937
CardioPulse
Weekly Journal Scan
Weekly Journal Scan: A CLEAR message questions the routine use of spironolactone in acute myocardial infarction
Daniela Pedicino and Massimo Volpe
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1359–1360, https://doi.org/10.1093/eurheartj/ehae936
Corrections
Correction to: 2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO)
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Page 1300, https://doi.org/10.1093/eurheartj/ehaf031
Correction to: Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and with clinical and genetic data improves risk stratification
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Page 1303, https://doi.org/10.1093/eurheartj/ehaf107
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals